The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity

Laryngoscope

Volumn 120, Issue 6, 2009, Pages 1208-1213

  Nader, Marc Elie ^a   Théorêt, Yves ^a   Saliba, Issam ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Chemotherapy; Chromatography; Cisplatin; Intratympanic injection; Lactate; N acetylcysteine; Ototoxicity

Indexed keywords

ACETYLCYSTEINE; CISPLATIN; LACTIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; COCHLEA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DIFFUSION; DRUG EFFECT; EAR PROTECTION; ELECTRON MICROSCOPY; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HAIR CELL; HEARING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; INNER EAR; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCANNING ELECTRON MICROSCOPE; STEREOCILIUM;

ACETYLCYSTEINE; ANIMALS; CISPLATIN; GUINEA PIGS; HEARING LOSS; LACTATES; MICROSCOPY, ELECTRON, SCANNING; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TYMPANIC MEMBRANE;

EID: 77953143898     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20892     Document Type: Article

References (14)

1. Antineoplastic agents. Brunton LL, Parker KL. Goodman and Gilman's Manual of Pharmacology and Therapeutics. New York, NY: McGraw-Hill; 2008:867-868.
2. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007;33:9-23. (Pubitemid 46137553)
3. Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmes P. Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pharmacol 1994;35:1-9. (Pubitemid 24356740)
4. Argyriou AA, Chroni E, Koutras A, et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 2006;14:1134-1140. (Pubitemid 44898796)
5. Ekborn A, Hansson J, Ehrsson H, et al. High-dose cisplatin with amifostine: ototoxicity and pharmacokinetics. Laryngoscope 2004;114:1660-1667. (Pubitemid 39278890)
6. Planting AS, Catimel G, de Mulder PH, et al. Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group. Ann Oncol 1999;10:693-700. (Pubitemid 29342375)
7. Choe WT, Chinosornvatana N, Chang KW. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol 2004;25:910-915. (Pubitemid 39491671)
8. van den Berg JH, Beijnen JH, Balm AJ, Schellens JH. Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev 2006;32:390-397.
9. Asarch R, Abramson M, Litton WB. Surgical anatomy of the guinea pig ear. Ann Otol Rhinol Laryngol 1975;84(2 pt 1):250-255.
10. Cardinaal RM, de Groot JC, Huizing EH, Veldman JE, Smoorenburg GF. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 2000;144:135-146.
11. Li G, Frenz DA, Brahmblatt S, et al. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001;22:163-176. (Pubitemid 32499698)
12. te Poele-Pothoff MT, van den Berg M, Franken DG, et al. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 1995;32(pt 2): 218-220.
13. Gaines Das R, North D. Implications of experimental technique for analysis and interpretation of data from animal experiments: outliers and increased variability resulting from failure of intraperitoneal injection procedures. Lab Anim 2007;41:312-320. (Pubitemid 47195603)
14. Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004;193: 25-30. (Pubitemid 38813422)